Phagenesis, a medical device company specializing in the treatment of swallowing disorders, successfully closes a $42M Series D financing round led by EQT Life Sciences and Sectoral Asset Management

MANCHESTER, England, March 4, 2024 /PRNewswire/ — Phagenesis, a pioneering UK company…

Landmark Clinical Approval for YOLT-201 Obtained by the NMPA

SHANGHAI, March 4, 2024 /PRNewswire/ — YolTech Therapeutics, a biotech company developing…

Trip.com Group To Showcase New Consumer Trends and AI Innovations at ITB Berlin 2024

BERLIN, March 4, 2024 /PRNewswire/ — Trip.com Group is gearing up to…

KT&G CEO candidate Kyung-man Bang receives positive evaluations from major financial institutions

– Morgan Stanley and Meritz Securities expect Mr. Bang’s appointment to drive…

LONGi and Ferroglobe Announce Silicon Long-Term Agreement

XI’AN, China, March 4, 2024 /PRNewswire/ — LONGi, the world’s leading Solar…

Hybribio Calls for Raising International HPV Awareness

GUANGZHOU, China, March 4, 2024 /PRNewswire/ — March 4th 2024 marks the…

ICP Hub Singapore to Showcase at Summit X 2024: Unveiling Innovations at Premier Exhibition Booth

SINGAPORE, March 4, 2024 /PRNewswire/ — ICP Hub Singapore is thrilled to…

Justin Yifu Lin: Chinese market crucial for high-tech firms in advanced countries

BEIJING, March 4, 2024 /PRNewswire/ — A news report from chinadaily.com.cn: jwplayer.key=”3Fznr2BGJZtpwZmA+81lm048ks6+0NjLXyDdsO2YkfE=”  …